Current Research: Retatrutide is the first triple agonist peptide targeting the Glucagon, GLP-1, and GIP receptors (3G), with EC50 values of 5.79 nM, 0.0643 nM, and 0.775 nM, respectively [1]. It is currently in the final stage of clinical trials, with many benefits that include maintaining healthy muscles.

Each capsule formulary has the added benefit of Sodium salcaprozate (SNAC) 3mg to enhance absorption. Comes in bulk size of 1.64 mm of size 1 mini capsules. Contact us for bulk pricing or contact packaging.